Author Correction: Humanizing the mdx mouse model of DMD: the long and the short of it
A correction to this paper has been published: https://doi.org/10.1038/s41536-020-00112-0.
Guardado en:
Autores principales: | Nora Yucel, Alex C. Chang, John W. Day, Nadia Rosenthal, Helen M. Blau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfd16b4fe1aa4a4d862608d0957e08c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Myogenic reprogramming of bone marrow derived cells in a W⁴¹Dmd(mdx) deficient mouse model.
por: Stuart Walsh, et al.
Publicado: (2011) -
PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Kasturi Sengupta, et al.
Publicado: (2020) -
Decrease in prosaposin in the Dystrophic mdx mouse brain.
por: Hui-Ling Gao, et al.
Publicado: (2013) -
Histochemistry and Morphometric Analysis of Muscle Fibers from Patients with Duchenne Muscular Dystrophy (DMD)
por: Cavalcanti,George Maciel, et al.
Publicado: (2011) -
Increased neointimal thickening in dystrophin-deficient mdx mice.
por: Uwe Rauch, et al.
Publicado: (2012)